enzymatic chip-seq kit Search Results


enzymatic chip-seq kit  (Chromatrap)
90
Chromatrap enzymatic chip-seq kit
Enzymatic Chip Seq Kit, supplied by Chromatrap, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pmc10473560-61-14-13?v=Chromatrap
Average 90 stars, based on 1 article reviews
enzymatic chip-seq kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nebnext enzymatic methyl seq kit  (New England Biolabs)
98
New England Biolabs nebnext enzymatic methyl seq kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Nebnext Enzymatic Methyl Seq Kit, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/bio_rxiv__2023__06__09__544393-440-31-36?v=New+England+Biolabs
Average 98 stars, based on 1 article reviews
nebnext enzymatic methyl seq kit - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier
chip-it express enzymatic shearing kit  (Active Motif)
90
Active Motif chip-it express enzymatic shearing kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Chip It Express Enzymatic Shearing Kit, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pmc10404622-190-6-10?v=Active+Motif
Average 90 stars, based on 1 article reviews
chip-it express enzymatic shearing kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
illumina chip seq prep kit  (Illumina Inc)
96
Illumina Inc illumina chip seq prep kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Illumina Chip Seq Prep Kit, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pmc06028126-136-19-19?v=Illumina+Inc
Average 96 stars, based on 1 article reviews
illumina chip seq prep kit - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
nebnext ultra ii dna library prep kit for illumina  (New England Biolabs)
99
New England Biolabs nebnext ultra ii dna library prep kit for illumina
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Nebnext Ultra Ii Dna Library Prep Kit For Illumina, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/custom%40e7645%4033397398?v=New+England+Biolabs
Average 99 stars, based on 1 article reviews
nebnext ultra ii dna library prep kit for illumina - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier
nextflex chip seq kit  (Bioo Scientific)
86
Bioo Scientific nextflex chip seq kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Nextflex Chip Seq Kit, supplied by Bioo Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pm26673823-241-44-47?v=Bioo+Scientific
Average 86 stars, based on 1 article reviews
nextflex chip seq kit - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
auto-histone chip-seq kit  (DIAGENODE DIAGNOSTICS)
90
DIAGENODE DIAGNOSTICS auto-histone chip-seq kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Auto Histone Chip Seq Kit, supplied by DIAGENODE DIAGNOSTICS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pmc03499526-185-7-16?v=DIAGENODE+DIAGNOSTICS
Average 90 stars, based on 1 article reviews
auto-histone chip-seq kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
chip it express enzymatic shearing kit  (Active Motif)
96
Active Motif chip it express enzymatic shearing kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Chip It Express Enzymatic Shearing Kit, supplied by Active Motif, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pmc07377900-173-10-18?v=Active+Motif
Average 96 stars, based on 1 article reviews
chip it express enzymatic shearing kit - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
chip-it express enzymatic kit  (Active Motif)
90
Active Motif chip-it express enzymatic kit
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Chip It Express Enzymatic Kit, supplied by Active Motif, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pm35831302-496-16-20?v=Active+Motif
Average 90 stars, based on 1 article reviews
chip-it express enzymatic kit - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nebnext ultra dna library prep kit for illumina  (New England Biolabs)
98
New England Biolabs nebnext ultra dna library prep kit for illumina
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Nebnext Ultra Dna Library Prep Kit For Illumina, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/custom%40e7370%4036195603?v=New+England+Biolabs
Average 98 stars, based on 1 article reviews
nebnext ultra dna library prep kit for illumina - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier
fugene hd  (Promega)
90
Promega fugene hd
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Fugene Hd, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/pm38444610-208-10-38?v=Promega
Average 90 stars, based on 1 article reviews
fugene hd - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
chamq sybr qpcr master mix  (Vazyme Biotech Co)
99
Vazyme Biotech Co chamq sybr qpcr master mix
A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured <t>by</t> <t>siQ-ChIP-seq)</t> versus average DNA methylation (measured by <t>EM-seq</t> of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .
Chamq Sybr Qpcr Master Mix, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enzymatic+chip-seq+kit/custom%40q311%4030220457?v=Vazyme+Biotech+Co
Average 99 stars, based on 1 article reviews
chamq sybr qpcr master mix - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured by siQ-ChIP-seq) versus average DNA methylation (measured by EM-seq of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .

Journal: bioRxiv

Article Title: Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling

doi: 10.1101/2023.06.09.544393

Figure Lengend Snippet: A) Histograms of Log 2 (FC) in H3K27me3 efficiency relative to Vehicle treated samples. Combo is 1 µM TAZ plus 30 nM DAC. Log 2 (FC) is averaged across biological duplicates. Dotted lines indicate the threshold for H3K27me3 signal considered significantly different from Vehicle (|Log 2 FC| ≥ 1). B) Genomic coverage (in bp) of significantly altered regions of H3K27me3 efficiency (|Log 2 FC| ≥ 1) relative to Vehicle. C-D) Fold enrichment overlap analysis of lost (TAZ/Combo) and gained (DAC 30 nM/DAC 300 nM) H3K27me3 efficiency regions relative to Vehicle (|Log 2 FC| ≥ 1) in relation to C) ChromHMM states and D) replication timing (RepliSeq) phases from HCT116. D30 and D300, 30 nM DAC and 300 nM DAC. E) Density scatterplots of average H3K27me3 efficiency (measured by siQ-ChIP-seq) versus average DNA methylation (measured by EM-seq of siQ-ChIP-seq fragments) for the indicated treatment conditions following 72-hour exposure in HCT116. Average values are plotted from biological duplicates across 100 bp bins. F-H) Average profiles for F) H3K27me3 efficiency, G) DNA methylation, and H) EZH2 occupancy at conserved genomic regions that show increased H3K27me3 levels following 30 nM DAC treatment (n=3,223 peaks). I-K) Average profiles for I) H3K27me3 efficiency, J) DNA methylation, and K) EZH2 occupancy at conserved Bivalent Enhancers (EnhBiv) that show increased H3K27me3 following 30 nM DAC treatment (n=185 enhancer regions). L) HOMER transcription factor motif enrichment analysis of EnhBiv regions that show increased H3K27me3 with 30 nM DAC treatment. %Targets, % of given regions with indicated motif; %BG, % of the queried representative background with indicated motif. See also Figure S4 .

Article Snippet: Libraries were prepared by the Van Andel Institute Genomics Core from an input of 41 ng to 51 ng of ChIP DNA (taken directly from DNA IP’d for siQ-ChIP-seq) using the NEBNext Enzymatic Methyl- seq Kit (New England Biolabs E7120L).

Techniques: ChIP-sequencing, DNA Methylation Assay

A) Integrative epigenomic analysis (rows) centered on the TSS of genes upregulated by the indicated inhibitor treatments (columns) in HCT116 following 72-hour treatment with 30 nM DAC and 1 µM TAZ. Average profiles for H3K27me3 and DNA methylation were determined from biological duplicate siQ-ChIP-seq and EM-seq measurements, respectively. EZH2, H3K4me3, and H3K27ac profiles were determined from publicly available ENCODE data for HCT116. B) Representative browser shots for a DAC-responsive locus ( SLC1A2) and a TAZ-responsive locus ( FAM189A2 ) demonstrating patterns observed in average profiles from A. C) Venn diagram of genes upregulated by combination treatment overlapped with genes that contain activating histone PTMs (H3K4me3/H3K27ac) in the promoter of their TSS (+/- 1000 bp). Combo only responsive genes are subdivided by the presence/absence of active histone PTMs in their promoters. D) Representative browser shots for the different subdivisions of promoter architecture of Combo only responsive genes derived from A and C . E) Integrative epigenomic analysis (rows) centered on the TSS’s of genes upregulated by the combination inhibitor treatment only (Combo only) subdivided by promoter histone PTM status from C . Average profiles for H3K27me3 and DNA methylation were determined from biological duplicate siQ-ChIP-seq and EM-seq measurements, respectively. EZH2, H3K4me3, and H3K27ac profiles were determined from ENCODE data publicly available for HCT116. F-G) Fold enrichment overlap analysis of genes upregulated by Combo only subdivided by the promoter histone PTM status with D) ChromHMM states and E) replication timing (RepliSeq) phases in HCT116. H-I) Hypergeometric overlap analysis of Combo only upregulated genes subdivided by promoter histone PTM status with H) GSEA C2: Chemical and Genetic perturbations related to known studies of PRC2 regulation and F) GSEA C3: TFT transcription factor targets. Heatmaps represent the significance of the overlap, number of genes in overlap provided in parentheses.

Journal: bioRxiv

Article Title: Select EZH2 inhibitors enhance the viral mimicry effects of DNMT inhibition through a mechanism involving calcium-calcineurin-NFAT signaling

doi: 10.1101/2023.06.09.544393

Figure Lengend Snippet: A) Integrative epigenomic analysis (rows) centered on the TSS of genes upregulated by the indicated inhibitor treatments (columns) in HCT116 following 72-hour treatment with 30 nM DAC and 1 µM TAZ. Average profiles for H3K27me3 and DNA methylation were determined from biological duplicate siQ-ChIP-seq and EM-seq measurements, respectively. EZH2, H3K4me3, and H3K27ac profiles were determined from publicly available ENCODE data for HCT116. B) Representative browser shots for a DAC-responsive locus ( SLC1A2) and a TAZ-responsive locus ( FAM189A2 ) demonstrating patterns observed in average profiles from A. C) Venn diagram of genes upregulated by combination treatment overlapped with genes that contain activating histone PTMs (H3K4me3/H3K27ac) in the promoter of their TSS (+/- 1000 bp). Combo only responsive genes are subdivided by the presence/absence of active histone PTMs in their promoters. D) Representative browser shots for the different subdivisions of promoter architecture of Combo only responsive genes derived from A and C . E) Integrative epigenomic analysis (rows) centered on the TSS’s of genes upregulated by the combination inhibitor treatment only (Combo only) subdivided by promoter histone PTM status from C . Average profiles for H3K27me3 and DNA methylation were determined from biological duplicate siQ-ChIP-seq and EM-seq measurements, respectively. EZH2, H3K4me3, and H3K27ac profiles were determined from ENCODE data publicly available for HCT116. F-G) Fold enrichment overlap analysis of genes upregulated by Combo only subdivided by the promoter histone PTM status with D) ChromHMM states and E) replication timing (RepliSeq) phases in HCT116. H-I) Hypergeometric overlap analysis of Combo only upregulated genes subdivided by promoter histone PTM status with H) GSEA C2: Chemical and Genetic perturbations related to known studies of PRC2 regulation and F) GSEA C3: TFT transcription factor targets. Heatmaps represent the significance of the overlap, number of genes in overlap provided in parentheses.

Article Snippet: Libraries were prepared by the Van Andel Institute Genomics Core from an input of 41 ng to 51 ng of ChIP DNA (taken directly from DNA IP’d for siQ-ChIP-seq) using the NEBNext Enzymatic Methyl- seq Kit (New England Biolabs E7120L).

Techniques: DNA Methylation Assay, ChIP-sequencing, Derivative Assay